메뉴 건너뛰기
Epilepsy Research
Volumn 68, Issue SUPPL. 2, 2006, Pages
Zonisamide as adjunctive therapy for refractory partial seizures
Author keywords

Clinical trial; Epilepsy; Partial seizures; Review; Zonisamide
Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PRIMIDONE; VALPROIC ACID; ZONISAMIDE;
EID: 32644458957     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2005.11.005     Document Type: Article
Times cited : (31)
References (8)
  • 1
    • 13144306049 scopus 로고    scopus 로고
    • Dose-dependent safety and efficacy of zonisamide: A randomized, double-blind, placebo-controlled study in patients with refractory partial seizures
    • M.J. Brodie, R. Duncan, H. Vespignani, A. Solyom, V. Bitenskyy, and C. Lucas Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures Epilepsia 46 2005 31 41
    • (2005) Epilepsia , vol.46 , pp. 31-41
    • Brodie, M.J.1    Duncan, R.2    Vespignani, H.3    Solyom, A.4    Bitenskyy, V.5    Lucas, C.6
  • 2
    • 0036047026 scopus 로고    scopus 로고
    • Zonisamide add-on for drug-resistant partial epilepsy
    • D.W. Chadwick, and A.G. Marson Zonisamide add-on for drug-resistant partial epilepsy Cochrane Database Syst. Rev. 2 2002 CD001416
    • (2002) Cochrane Database Syst. Rev. , vol.2 , pp. 001416
    • Chadwick, D.W.1    Marson, A.G.2
  • 3
    • 0035960602 scopus 로고    scopus 로고
    • Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures
    • the Zonisamide 922 Trial Group I.E.
    • E. Faught, R. Ayala, G.G. Montouris, I.E. Leppik the Zonisamide 922 Trial Group Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures Neurology 57 2001 1774 1779
    • (2001) Neurology , vol.57 , pp. 1774-1779
    • Faught, E.1    Ayala, R.2    Montouris, G.G.3    Leppik4
  • 4
    • 7044271164 scopus 로고    scopus 로고
    • Zonisamide: Chemistry, mechanism of action, and pharmacokinetics
    • I.E. Leppik Zonisamide: chemistry, mechanism of action, and pharmacokinetics Seizure 13 Suppl. 1 2004 5 9
    • (2004) Seizure , vol.13 , Issue.1 SUPPL. , pp. 5-9
    • Leppik, I.E.1
  • 5
    • 0032441352 scopus 로고    scopus 로고
    • Zonisamide: Pharmacology and clinical efficacy in epilepsy
    • Y. Masuda, M. Ishizaki, and M. Shimizu Zonisamide: pharmacology and clinical efficacy in epilepsy CNS Drug Rev. 4 1998 341 360
    • (1998) CNS Drug Rev. , vol.4 , pp. 341-360
    • Masuda, Y.1    Ishizaki, M.2    Shimizu, M.3
  • 6
    • 3042636758 scopus 로고    scopus 로고
    • Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures
    • J.C. Sackellares, R.E. Ramsay, B.J. Wilder, T.R. Browne, and M.K. Shellenberger Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures Epilepsia 45 2004 610 617
    • (2004) Epilepsia , vol.45 , pp. 610-617
    • Sackellares, J.C.1    Ramsay, R.E.2    Wilder, B.J.3    Browne, T.R.4    Shellenberger, M.K.5
  • 8
    • 7044231529 scopus 로고    scopus 로고
    • Overview of Japanese experience - Controlled and uncontrolled trials
    • K. Yagi Overview of Japanese experience - controlled and uncontrolled trials Seizure 13 Suppl. 1 2004 11 15
    • (2004) Seizure , vol.13 , Issue.1 SUPPL. , pp. 11-15
    • Yagi, K.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.